A stock that yields 69% a year? Really?
In today’s helter-skelter market, most investors would be happy with stocks yielding 4% or 5%. But they’d be setting their sights too low. Because I’ve built a portfolio that pays us a 69% cash on cash return — with no leverage, options, or gimmicks.
Details here.
pixel

CARA Insider Trading (Cara Therapeutics)

Insider Ownership Percentage: 6.20%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $1,876,951.66

Cara Therapeutics Insider Trading History Chart

Cara Therapeutics Share Price & Price History

$14.45
▼ -0.1 (-0.69%)
As of 06/21/2021 03:55 PM ET
Days: 30 | 90 | 365
Learn How to Analyze Your Market and Trading Plan
Custom-design an options strategy to fit your market outlook. This guide goes beyond the basics to help you understand how to evaluate a strategy’s risk and reward. Start with your market outlook, then hone in on your strategy based on the risk you’re willing to take.
Download Your FREE Options Trading Strategy Guide today!
pixel

Cara Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
6/7/2021Martin VogelbaumDirectorSell8,640$13.05$112,752.0028,800View SEC Filing Icon  
4/21/2021Joana GoncalvesInsiderSell3,000$27.63$82,890.0043,610View SEC Filing Icon  
3/22/2021Joana GoncalvesInsiderSell3,000$19.65$58,950.0030,610View SEC Filing Icon  
3/5/2021Derek T ChalmersCEOSell3,103$17.98$55,791.94953,614View SEC Filing Icon  
3/5/2021Frederique Ph.D. MenzaghiSVPSell3,358$17.98$60,376.84122,677View SEC Filing Icon  
3/5/2021Scott TerrillionInsiderSell3,090$17.98$55,558.2054,432View SEC Filing Icon  
2/25/2021Derek T ChalmersCEOSell11,729$19.33$226,721.57955,343View SEC Filing Icon  
2/25/2021Frederique Ph.D. MenzaghiSVPSell5,003$19.33$96,707.99117,680View SEC Filing Icon  
2/25/2021Scott TerrillionInsiderSell4,004$19.33$77,397.3248,436View SEC Filing Icon  
1/21/2021Joana GoncalvesInsiderSell2,000$20.12$40,240.0028,075View SEC Filing Icon  
12/30/2020Derek T ChalmersCEOSell6,078$15.30$92,993.40936,593View SEC Filing Icon  
12/30/2020Frederique Ph.D. MenzaghiSVPSell2,812$15.30$43,023.60109,680View SEC Filing Icon  
12/30/2020Scott TerrillionInsiderSell1,946$15.30$29,773.8042,436View SEC Filing Icon  
12/28/2020Derek T ChalmersCEOSell5,000$16.00$80,000.00947,671View SEC Filing Icon  
12/21/2020Joana GoncalvesInsiderSell2,000$15.00$30,000.0027,373View SEC Filing Icon  
12/16/2020Derek T ChalmersCEOSell5,000$14.95$74,750.00928,921View SEC Filing Icon  
12/10/2020Derek T ChalmersCEOSell7,500$15.29$114,675.00933,921View SEC Filing Icon  
11/23/2020Joana GoncalvesInsiderSell2,000$15.31$30,620.0029,373View SEC Filing Icon  
11/19/2020Christopher PosnerDirectorSell2,000$15.82$31,640.0011,200View SEC Filing Icon  
11/17/2020Derek T ChalmersCEOSell11,799$16.00$188,784.00941,421View SEC Filing Icon  
11/17/2020Martin VogelbaumDirectorSell6,000$16.09$96,540.0014,400View SEC Filing Icon  
11/10/2020Joana GoncalvesInsiderSell2,000$15.00$30,000.0031,373View SEC Filing Icon  
10/20/2020Joana GoncalvesInsiderSell2,000$15.00$30,000.0033,373View SEC Filing Icon  
9/3/2020Derek T ChalmersCEOSell3,201$16.00$51,216.00953,220View SEC Filing Icon  
7/1/2020Derek T ChalmersCEOSell5,000$17.11$85,550.00961,421View SEC Filing Icon  
6/12/2020Joana GoncalvesInsiderSell10,627$15.05$159,936.3546,000View SEC Filing Icon  
6/3/2020Derek T ChalmersCEOSell4,300$16.01$68,843.00970,721View SEC Filing Icon  
6/1/2020Derek T ChalmersCEOSell700$16.00$11,200.00970,721View SEC Filing Icon  
6/1/2020Jeffrey L IvesDirectorSell1,000$16.00$16,000.007,000View SEC Filing Icon  
5/22/2020Derek T ChalmersCEOSell371$16.00$5,936.00975,292View SEC Filing Icon  
5/20/2020Derek T ChalmersCEOSell1,200$16.00$19,200.00975,292View SEC Filing Icon  
5/12/2020Derek T ChalmersCEOSell4,929$16.00$78,864.00976,492View SEC Filing Icon  
5/12/2020Jeffrey L IvesDirectorSell2,500$16.00$40,000.008,500View SEC Filing Icon  
4/21/2020Derek T ChalmersCEOSell6,348$15.56$98,774.88987,769View SEC Filing Icon  
4/21/2020Frederique Ph.D. MenzaghiSVPSell12,894$15.58$200,888.52117,386View SEC Filing Icon  
4/21/2020Jeffrey L IvesDirectorSell2,500$16.00$40,000.008,500View SEC Filing Icon  
4/21/2020Scott TerrillionInsiderSell2,721$15.56$42,338.7641,103View SEC Filing Icon  
3/4/2020Jeffrey L IvesDirectorSell2,500$16.00$40,000.008,500View SEC Filing Icon  
1/2/2020Derek T ChalmersCEOSell10,000$16.05$160,500.00917,769View SEC Filing Icon  
1/2/2020Jeffrey L IvesDirectorSell2,500$16.13$40,325.008,500View SEC Filing Icon  
12/4/2019Derek T ChalmersCEOSell10,699$17.05$182,417.95918,468View SEC Filing Icon  
12/4/2019Mani MohindruCFOSell4,755$17.05$81,072.7522,196View SEC Filing Icon  
12/4/2019Scott TerrillionInsiderSell3,980$17.05$67,859.0020,749View SEC Filing Icon  
12/2/2019Derek T ChalmersCEOSell10,000$25.79$257,900.00918,468View SEC Filing Icon  
12/2/2019Jeffrey L IvesDirectorSell2,500$25.83$64,575.008,500View SEC Filing Icon  
11/1/2019Derek T ChalmersCEOSell5,000$20.79$103,950.00928,468View SEC Filing Icon  
11/1/2019Jeffrey L IvesDirectorSell2,500$20.68$51,700.008,500View SEC Filing Icon  
10/25/2019Frederique Ph.D. MenzaghiSVPSell4,000$19.91$79,640.0063,886View SEC Filing Icon  
10/18/2019Frederique Ph.D. MenzaghiSVPSell4,000$19.33$77,320.0067,886View SEC Filing Icon  
10/11/2019Frederique Ph.D. MenzaghiSVPSell4,000$18.70$74,800.0071,886View SEC Filing Icon  
10/4/2019Frederique Ph.D. MenzaghiSVPSell4,000$19.19$76,760.0075,886View SEC Filing Icon  
10/1/2019Derek T ChalmersCEOSell10,000$18.28$182,800.00933,468View SEC Filing Icon  
10/1/2019Jeffrey L IvesDirectorSell2,500$18.21$45,525.008,500View SEC Filing Icon  
9/3/2019Derek T ChalmersCEOSell5,000$23.26$116,300.00943,468View SEC Filing Icon  
9/3/2019Frederique Ph.D. MenzaghiSVPSell20,000$22.92$458,400.0079,886View SEC Filing Icon  
9/3/2019Jeffrey L IvesDirectorSell2,500$23.31$58,275.008,500View SEC Filing Icon  
8/1/2019Derek T ChalmersCEOSell10,000$23.27$232,700.00948,468View SEC Filing Icon  
8/1/2019Frederique Ph.D. MenzaghiSVPSell20,000$23.24$464,800.0099,886View SEC Filing Icon  
8/1/2019Jeffrey L IvesDirectorSell2,500$23.24$58,100.008,500View SEC Filing Icon  
7/17/2019Frederique Ph.D. MenzaghiInsiderSell8,996$27.50$247,390.00119,886View SEC Filing Icon  
7/15/2019Mani MohindruCFOSell37,431$25.00$935,775.0051,294View SEC Filing Icon  
7/1/2019Frederique Ph.D. MenzaghiInsiderSell20,000$21.90$438,000.00128,882View SEC Filing Icon  
7/1/2019Jeffrey L IvesDirectorSell2,500$21.75$54,375.008,500View SEC Filing Icon  
5/29/2019Derek T ChalmersCEOSell5,528$21.42$118,409.76963,996View SEC Filing Icon  
5/29/2019Frederique Ph.D. MenzaghiInsiderSell11,397$21.19$241,502.43160,279View SEC Filing Icon  
5/29/2019Mani MohindruCFOSell2,496$21.39$53,389.4416,359View SEC Filing Icon  
3/13/2019Frederique Ph.D. MenzaghiInsiderSell20,000$18.65$373,000.00139,582View SEC Filing Icon  
3/13/2019Mani MohindruCFOSell16,041$19.12$306,703.9224,067View SEC Filing Icon  
3/1/2019Derek T ChalmersCEOSell9,792$17.04$166,855.68943,996View SEC Filing Icon  
2/28/2019Frederique Ph.D. MenzaghiSVPSell1,500$17.50$26,250.00142,779View SEC Filing Icon  
2/25/2019Frederique Ph.D. MenzaghiSVPSell2,200$17.50$38,500.00144,279View SEC Filing Icon  
2/1/2019Derek T ChalmersCEOSell20,000$14.99$299,800.00953,788View SEC Filing Icon  
1/4/2019Derek T ChalmersCEOSell20,000$13.61$272,200.00View SEC Filing Icon  
12/28/2018Derek T ChalmersCEOSell15,825$12.53$198,287.25993,788View SEC Filing Icon  
12/28/2018Derek T ChalmersCEOSell15,825$12.53$198,287.25View SEC Filing Icon  
12/28/2018Frederique Ph.D. MenzaghiSVPSell4,300$12.53$53,879.00View SEC Filing Icon  
12/28/2018Frederique Ph.D. MenzaghiSVPSell4,300$12.53$53,879.00146,479View SEC Filing Icon  
12/28/2018Mani MohindruCFOSell4,500$12.55$56,475.008,026View SEC Filing Icon  
12/28/2018Mani MohindruCFOSell4,500$12.55$56,475.00View SEC Filing Icon  
12/28/2018Scott TerrillionInsiderSell3,100$12.51$38,781.006,386View SEC Filing Icon  
12/28/2018Scott TerrillionInsiderSell3,100$12.51$38,781.00View SEC Filing Icon  
11/15/2018Mani MohindruCFOSell16,042$18.50$296,777.00View SEC Filing Icon  
11/1/2018Derek T ChalmersCEOSell20,000$18.78$375,600.00991,392View SEC Filing Icon  
11/1/2018Frederique Ph.D. MenzaghiSVPSell3,000$18.77$56,310.00145,000View SEC Filing Icon  
10/17/2018Joseph William StaufferInsiderSell11,442$20.13$230,327.462,970View SEC Filing Icon  
10/17/2018Mani MohindruCFOSell16,042$20.19$323,887.9816,042View SEC Filing Icon  
10/1/2018Derek T ChalmersCEOSell20,000$23.79$475,800.00View SEC Filing Icon  
10/1/2018Frederique Ph.D. MenzaghiSVPSell3,000$23.99$71,970.00View SEC Filing Icon  
9/4/2018Derek T ChalmersCEOSell20,000$19.71$394,200.001,031,392View SEC Filing Icon  
9/4/2018Frederique Ph.D. MenzaghiSVPSell3,000$19.81$59,430.0098,000View SEC Filing Icon  
8/20/2018Frederique Ph.D. MenzaghiSVPSell3,000$18.89$56,670.00101,000View SEC Filing Icon  
7/10/2018Derek T ChalmersCEOSell20,000$20.64$412,800.001,051,392View SEC Filing Icon  
7/2/2018Frederique Ph.D. MenzaghiSVPSell3,000$19.00$57,000.00104,000View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Cara Therapeutics (NASDAQ:CARA)

64.66% of Cara Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Cara Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/19/2021Squarepoint Ops LLC10,664$0.23M0.0%N/A0.021%Search for SEC Filing on Google Icon
5/18/2021Disciplined Growth Investors Inc. MN593,483$12.89M0.3%-14.0%1.186%Search for SEC Filing on Google Icon
5/18/2021Morgan Stanley233,168$5.06M0.0%+77.6%0.466%Search for SEC Filing on Google Icon
5/18/2021Cubist Systematic Strategies LLC56,115$1.22M0.0%+37.1%0.112%Search for SEC Filing on Google Icon
5/17/2021PDT Partners LLC65,067$1.41M0.1%-10.6%0.130%Search for SEC Filing on Google Icon
5/17/2021AQR Capital Management LLC10,020$0.22M0.0%N/A0.020%Search for SEC Filing on Google Icon
5/17/2021Royal Bank of Canada4,644$0.10M0.0%+67.6%0.009%Search for SEC Filing on Google Icon
5/17/2021Price T Rowe Associates Inc. MD2,299,299$49.92M0.0%-5.3%4.594%Search for SEC Filing on Google Icon
5/17/2021Janus Henderson Group PLC170,475$3.70M0.0%N/A0.341%Search for SEC Filing on Google Icon
5/17/2021Nuveen Asset Management LLC615,417$13.36M0.0%+64.1%1.230%Search for SEC Filing on Google Icon
5/17/2021Goldman Sachs Group Inc.442,989$9.62M0.0%-26.3%0.885%Search for SEC Filing on Google Icon
5/14/2021Prosight Management LP100,000$2.17M1.8%-66.0%0.200%Search for SEC Filing on Google Icon
5/14/2021Dimensional Fund Advisors LP63,369$1.37M0.0%-7.8%0.127%Search for SEC Filing on Google Icon
5/14/2021First Manhattan Co.2,169,351$47.10M0.2%-18.4%4.334%Search for SEC Filing on Google Icon
5/14/2021UBS Asset Management Americas Inc.60,586$1.32M0.0%+1.7%0.121%Search for SEC Filing on Google Icon
5/14/2021Stifel Financial Corp90,508$1.97M0.0%-1.3%0.181%Search for SEC Filing on Google Icon
5/14/2021Credit Suisse AG40,667$0.88M0.0%-18.5%0.081%Search for SEC Filing on Google Icon
5/14/2021Quantbot Technologies LP3,062$66K0.0%+3,982.7%0.006%Search for SEC Filing on Google Icon
5/13/2021RHO Capital Partners Inc.2,549,058$55.34M5.3%-8.9%5.093%Search for SEC Filing on Google Icon
5/13/2021SG Americas Securities LLC54,433$1.18M0.0%-63.9%0.109%Search for SEC Filing on Google Icon
5/13/2021Barclays PLC39,914$0.87M0.0%+140.6%0.080%Search for SEC Filing on Google Icon
5/13/2021Renaissance Technologies LLC261,450$5.68M0.0%-6.2%0.522%Search for SEC Filing on Google Icon
5/13/2021Penserra Capital Management LLC311,713$6.77M0.1%+172.9%0.623%Search for SEC Filing on Google Icon
5/13/2021Bank of New York Mellon Corp169,627$3.68M0.0%-4.8%0.339%Search for SEC Filing on Google Icon
5/13/2021Citigroup Inc.6,417$0.14M0.0%-48.7%0.013%Search for SEC Filing on Google Icon
5/13/2021Martingale Asset Management L P11,435$0.25M0.0%N/A0.023%Search for SEC Filing on Google Icon
5/13/2021Bank of Montreal Can8,004$0.22M0.0%-28.5%0.016%Search for SEC Filing on Google Icon
5/13/2021Allianz Asset Management GmbH14,909$0.32M0.0%N/A0.030%Search for SEC Filing on Google Icon
5/12/2021Northern Trust Corp490,892$10.66M0.0%-6.8%0.981%Search for SEC Filing on Google Icon
5/12/2021Geode Capital Management LLC721,938$15.67M0.0%+6.8%1.443%Search for SEC Filing on Google Icon
5/12/2021Pinnacle Associates Ltd.344,651$7.48M0.1%-7.6%0.689%Search for SEC Filing on Google Icon
5/12/2021Wellington Shields Capital Management LLC108,550$2.36M0.2%N/A0.217%Search for SEC Filing on Google Icon
5/12/2021UBS Group AG18,808$0.41M0.0%-32.2%0.038%Search for SEC Filing on Google Icon
5/11/2021Aigen Investment Management LP14,171$0.31M0.0%-64.2%0.028%Search for SEC Filing on Google Icon
5/11/2021Acadian Asset Management LLC6,630$0.15M0.0%N/A0.013%Search for SEC Filing on Google Icon
5/11/2021Davy Global Fund Management Ltd55,397$1.20M0.2%+222.4%0.111%Search for SEC Filing on Google Icon
5/11/2021Alpine Woods Capital Investors LLC60,808$1.32M0.1%+5.0%0.122%Search for SEC Filing on Google Icon
5/11/2021Vontobel Holding Ltd.10,000$0.22M0.0%N/A0.020%Search for SEC Filing on Google Icon
5/11/2021Silvant Capital Management LLC9,676$0.21M0.0%N/A0.019%Search for SEC Filing on Google Icon
5/10/2021Russell Investments Group Ltd.56,599$1.23M0.0%-39.2%0.113%Search for SEC Filing on Google Icon
5/10/2021Kestra Advisory Services LLC11,103$0.24M0.0%-19.7%0.022%Search for SEC Filing on Google Icon
5/10/2021State Board of Administration of Florida Retirement System59,212$1.29M0.0%+227.8%0.118%Search for SEC Filing on Google Icon
5/7/2021BlackRock Inc.3,686,965$80.04M0.0%+1.5%7.368%Search for SEC Filing on Google Icon
5/7/2021Cambridge Investment Research Advisors Inc.13,332$0.29M0.0%+28.0%0.027%Search for SEC Filing on Google Icon
5/7/2021BNP Paribas Arbitrage SA16,364$0.36M0.0%+26.6%0.033%Search for SEC Filing on Google Icon
5/7/2021Cypress Capital Management LLC WY72,315$1.57M1.4%-11.6%0.145%Search for SEC Filing on Google Icon
5/7/2021Swiss National Bank108,200$2.35M0.0%+7.3%0.216%Search for SEC Filing on Google Icon
5/6/2021Arizona State Retirement System13,781$0.30M0.0%+6.8%0.028%Search for SEC Filing on Google Icon
5/6/2021Rhumbline Advisers53,569$1.16M0.0%-6.1%0.107%Search for SEC Filing on Google Icon
5/4/2021Victory Capital Management Inc.45,218$0.98M0.0%+19.0%0.090%Search for SEC Filing on Google Icon
5/3/2021Chartwell Investment Partners LLC14,083$0.31M0.0%N/A0.028%Search for SEC Filing on Google Icon
5/3/2021The Manufacturers Life Insurance Company24,100$0.52M0.0%-5.7%0.048%Search for SEC Filing on Google Icon
4/30/2021Virginia Retirement Systems ET AL38,900$0.85M0.0%+42.0%0.078%Search for SEC Filing on Google Icon
4/27/2021State of New Jersey Common Pension Fund D111,153$2.41M0.0%-27.6%0.223%Search for SEC Filing on Google Icon
4/26/2021Assenagon Asset Management S.A.63,882$1.39M0.0%+80.7%0.128%Search for SEC Filing on Google Icon
4/23/2021Strs Ohio2,200$47K0.0%N/A0.004%Search for SEC Filing on Google Icon
4/15/2021Rothschild Investment Corp IL39,000$0.85M0.1%+7.1%0.078%Search for SEC Filing on Google Icon
4/15/2021DnB Asset Management AS17,210$0.37M0.0%-10.4%0.035%Search for SEC Filing on Google Icon
4/8/2021Baldwin Brothers Inc. MA15,327$0.33M0.0%-6.1%0.031%Search for SEC Filing on Google Icon
4/5/2021Woodstock Corp30,149$0.66M0.1%+62.7%0.060%Search for SEC Filing on Google Icon
3/8/2021Dimensional Fund Advisors LP68,753$1.04M0.0%+2.5%0.138%Search for SEC Filing on Google Icon
2/25/2021Dimensional Fund Advisors LP68,753$1.04M0.0%+2.5%0.138%Search for SEC Filing on Google Icon
2/25/2021Hsbc Holdings PLC12,888$0.20M0.0%N/A0.026%Search for SEC Filing on Google Icon
2/23/2021Principal Financial Group Inc.10,423$0.16M0.0%N/A0.021%Search for SEC Filing on Google Icon
2/19/2021JPMorgan Chase & Co.98,521$1.49M0.0%-2.7%0.198%Search for SEC Filing on Google Icon
2/17/2021Freedman Financial Associates Inc.5,400$82K0.1%N/A0.011%Search for SEC Filing on Google Icon
2/16/2021Nuveen Asset Management LLC374,936$5.67M0.0%-33.2%0.752%Search for SEC Filing on Google Icon
2/16/2021Captrust Financial Advisors3,000$45K0.0%+20.0%0.006%Search for SEC Filing on Google Icon
2/16/2021Price T Rowe Associates Inc. MD2,429,235$36.75M0.0%-23.6%4.875%Search for SEC Filing on Google Icon
2/16/2021Virginia Retirement Systems ET AL27,400$0.42M0.0%N/A0.055%Search for SEC Filing on Google Icon
2/16/2021New York Life Investments Alternatives17,985$0.27M0.2%N/A0.036%Search for SEC Filing on Google Icon
2/16/2021ETF Managers Group LLC434,527$6.57M0.1%-32.8%0.872%Search for SEC Filing on Google Icon
2/16/2021Engineers Gate Manager LP27,330$0.41M0.0%+2.6%0.055%Search for SEC Filing on Google Icon
2/16/2021Charles Schwab Investment Management Inc.279,758$4.23M0.0%+0.5%0.561%Search for SEC Filing on Google Icon
2/13/2021American International Group Inc.23,928$0.36M0.0%-2.8%0.048%Search for SEC Filing on Google Icon
2/12/2021Stifel Financial Corp91,692$1.39M0.0%+4.8%0.184%Search for SEC Filing on Google Icon
2/12/2021Penserra Capital Management LLC114,205$1.73M0.0%+73.2%0.229%Search for SEC Filing on Google Icon
2/12/2021Raymond James Financial Services Advisors Inc.11,471$0.17M0.0%-6.2%0.023%Search for SEC Filing on Google Icon
2/12/2021The Manufacturers Life Insurance Company25,567$0.39M0.0%+3.1%0.051%Search for SEC Filing on Google Icon
2/12/2021Credit Suisse AG49,878$0.76M0.0%+47.1%0.100%Search for SEC Filing on Google Icon
2/12/2021Virtus ETF Advisers LLC19,799$0.30M0.1%-3.3%0.040%Search for SEC Filing on Google Icon
2/11/2021Northern Trust Corp526,543$7.97M0.0%-1.2%1.057%Search for SEC Filing on Google Icon
2/11/2021Barclays PLC16,589$0.25M0.0%-25.0%0.033%Search for SEC Filing on Google Icon
2/10/2021Rhumbline Advisers57,036$0.86M0.0%+3.9%0.114%Search for SEC Filing on Google Icon
2/10/2021Renaissance Technologies LLC278,714$4.22M0.0%-6.8%0.559%Search for SEC Filing on Google Icon
2/9/2021Wells Fargo & Company MN126,688$1.92M0.0%+17.4%0.254%Search for SEC Filing on Google Icon
2/9/2021Bank of New York Mellon Corp178,248$2.70M0.0%-1.6%0.358%Search for SEC Filing on Google Icon
2/9/2021ProShare Advisors LLC16,809$0.25M0.0%+33.4%0.034%Search for SEC Filing on Google Icon
2/8/2021Alliancebernstein L.P.49,000$0.74M0.0%-20.6%0.098%Search for SEC Filing on Google Icon
2/8/2021Russell Investments Group Ltd.93,162$1.41M0.0%+45.8%0.187%Search for SEC Filing on Google Icon
2/5/2021BlackRock Inc.3,632,266$54.96M0.0%-1.7%7.289%Search for SEC Filing on Google Icon
2/5/2021Aperio Group LLC10,014$0.15M0.0%N/A0.020%Search for SEC Filing on Google Icon
2/5/2021SG Americas Securities LLC150,901$2.28M0.0%+13.4%0.303%Search for SEC Filing on Google Icon
2/4/2021Cambridge Investment Research Advisors Inc.10,416$0.16M0.0%N/A0.021%Search for SEC Filing on Google Icon
2/4/2021State of Wisconsin Investment Board58,700$0.89M0.0%-11.1%0.118%Search for SEC Filing on Google Icon
2/3/2021State of New Jersey Common Pension Fund D153,536$2.32M0.0%+2.9%0.308%Search for SEC Filing on Google Icon
2/1/2021Alpine Woods Capital Investors LLC57,927$0.88M0.1%+217.6%0.116%Search for SEC Filing on Google Icon
2/1/2021Victory Capital Management Inc.38,005$0.58M0.0%-5.3%0.076%Search for SEC Filing on Google Icon
2/1/2021Assenagon Asset Management S.A.35,359$0.54M0.0%-78.5%0.071%Search for SEC Filing on Google Icon
1/30/2021Davy Global Fund Management Ltd17,184$0.26M0.1%N/A0.034%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Cara Therapeutics logo
Cara Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and immune cells. Its lead product candidate includes KORSUVA (CR845/ difelikefalin) injection, which is in Phase III clinical trial for the treatment of patients with moderate-to-severe chronic kidney disease-associated pruritus (CKD-aP) undergoing hemodialysis. The company is also developing Oral KORSUVA (CR845/difelikefalin), which has completed Phase II clinical trial for the treatment of pruritus in stage III-V CKD patients; in Phase II clinical trial for treating pruritus chronic liver disease; and in Phase II clinical trial for the treatment of pruritus associated with atopic dermatitis. In addition, it is developing CR845/difelikefalin Injection, which has completed Phase II/III clinical trial for the treatment of acute post-operative pain. The company has license agreements with Maruishi Pharmaceutical Co., Ltd to develop, manufacture, and commercialize drug products containing CR845/difelikefalin for acute pain and uremic pruritus in Japan; and Chong Kun Dang Pharmaceutical Corporation to develop, manufacture, and commercialize drug products containing CR845/difelikefalin in South Korea. Cara Therapeutics, Inc. was founded in 2004 and is headquartered in Stamford, Connecticut.
Read More on Cara Therapeutics

Today's Range

Now: $14.45
$14.09
$14.60

50 Day Range

MA: $17.05
$12.38
$28.52

52 Week Range

Now: $14.45
$11.80
$29.65

Volume

20,297 shs

Average Volume

944,263 shs

Market Capitalization

$723.25 million

P/E Ratio

62.83

Dividend Yield

N/A

Beta

1.13

Who are the company insiders with the largest holdings of Cara Therapeutics?

Cara Therapeutics' top insider investors include:
  1. Derek T Chalmers (CEO)
  2. Frederique PhD Menzaghi (Insider)
  3. Frederique PhD Menzaghi (SVP)
  4. Scott Terrillion (Insider)
  5. Mani Mohindru (CFO)
  6. Joana Goncalves (Insider)
  7. Martin Vogelbaum (Director)
  8. Christopher Posner (Director)
  9. Jeffrey L Ives (Director)

Who are the major institutional investors of Cara Therapeutics?

Cara Therapeutics' top institutional investors include:
  1. BlackRock Inc. — 7.37%
  2. RHO Capital Partners Inc. — 5.09%
  3. Price T Rowe Associates Inc. MD — 4.59%
  4. First Manhattan Co. — 4.33%
  5. Geode Capital Management LLC — 1.44%
  6. Nuveen Asset Management LLC — 1.23%

Which institutional investors are selling Cara Therapeutics stock?

During the last quarter, CARA stock was sold by these institutional investors:
  1. First Manhattan Co.
  2. RHO Capital Partners Inc.
  3. Prosight Management LP
  4. Goldman Sachs Group Inc.
  5. Price T Rowe Associates Inc. MD
  6. SG Americas Securities LLC
  7. Disciplined Growth Investors Inc. MN
  8. State of New Jersey Common Pension Fund D
During the previous year, company insiders that have sold Cara Therapeutics company stock include:
  1. Derek T Chalmers (CEO)
  2. Frederique PhD Menzaghi (Insider)
  3. Frederique PhD Menzaghi (SVP)
  4. Scott Terrillion (Insider)
  5. Mani Mohindru (CFO)
  6. Joana Goncalves (Insider)

Which institutional investors are buying Cara Therapeutics stock?

During the previous quarter, CARA stock was purchased by institutional investors including:
  1. Nuveen Asset Management LLC
  2. Penserra Capital Management LLC
  3. Janus Henderson Group PLC
  4. Wellington Shields Capital Management LLC
  5. Morgan Stanley
  6. BlackRock Inc.
  7. Geode Capital Management LLC
  8. State Board of Administration of Florida Retirement System
The BIG CON “Screwing Americans”
The rich and powerful are thrilled... Inflation is GREAT for them. It’s everyone else who’ll get screwed. But according to an ex-Wall Street vet, there’s actually a way for YOU to turn the tables – just make this one move before July 29th.
Click here to see why